Osteoarthritis Market Global Trends, Key Players, Industry Analysis and Forecast to 2030

 

Osteoarthritis Treatment Market

The Osteoarthritis Drug Market is anticipated to reach USD 8,751 Million by 2030 at 9.10% CAGR during the forecast period 2022-2030.

The market is growing persistently on account of growing global geriatric population as it accounts for more disability among the elderly population than any other disease. Elderly patients have been reported to experience radiographic osteoarthritis which increases as patients age. Rising populace of obesity is also considered to be the driving factor in the growth of the global osteoarthritis market since obesity has also been identified as a risk factor for osteoarthritis. Obesity reduces the skeletal-weight-to-body-mass which results in compressive forces to joints.

Competitive Landscape

The key players in the global osteoarthritis market include

  • Regeneron (U.S.),
  • Novartis AG (Europe),
  • TissueGene Inc. (U.S.),
  • Eli Lilly and Company. (U.S.),
  • Pfizer Inc. (U.S.),
  • Abbott. (U.S.),
  • Ampio Pharmaceuticals Inc. (U.S.),
  • ABIOGEN PHARMA S.p.A (Europe), and
  • Merck Sharp & Dohme Corp. (U.S.).

Segmentation

The global osteoarthritis market has been segmented based on type, diagnosis, treatment, and end users. By type, the osteoarthritis disability rating market has been segmented into hip osteoarthritis, wrist osteoarthritis, spinal osteoarthritis, and others. 

  • By diagnosis, the osteoarthritis disability rating has been segmented into imaging, joint fluid analysis, and others. The imaging segment is sub-segmented into X-rays, magnetic resonance imaging (MRI), and others. 
  • By treatment, the osteoarthritis has been segmented into medication, surgery, therapy, and others. The medication segment has been further segmented into analgesics and non-steroidal anti-inflammatory drugs, and others. The analgesic sub-segment has been further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub-segment has been further segmented into aspirin, ibuprofen, naproxen sodium and naproxen, and others. 
  • By end users, the osteoarthritis segment has been hospitals & clinics, medical institutes, research organization, and others.

Regional Analysis

The global osteoarthritis market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas hold the dominant position in the global osteoarthritis market. A robust healthcare sector, huge osteoarthritis patient pool, and high healthcare expenditure support the growth of the Americas market. 

Europe has commanded the second position in the global osteoarthritis market. Availability of funds for research and development activities coupled with government support, high healthcare expenditure and growing prevalence of osteoarthritis in the region propels the growth of the Europe market. 

Asia Pacific follows Europe in the global osteoarthritis market. The presence of a huge patient population, rising healthcare investments in the developing economies, and the untapped markets of the region provide a lucrative opportunity for market expansion. Moreover, favorable government policies aid market growth and will help Asia Pacific to emerge as the fastest growing market for osteoarthritis. 

The Middle East & Africa holds the least share in the global osteoarthritis market. Poor economic condition and low penetration of healthcare limit the growth of the market, especially in the Africa region and most of the market share is held by the Middle East market. The healthcare sector is well-developed in the Gulf countries which helps the Middle East market progress. 

Industry Updates

  • In August 2018, the FDA launched new draft guidance for Osteoarthritis Treatments. The new set of rules will guide drug and medical device manufacturers to develop treatments for osteoarthritis. 

Related Report-

https://ionooz.com/read-blog/13045

https://telegra.ph/Anti-Asthma-Drugs-Market-Worldwide-Demand-and-Growth-Analysis-Report-2022-2030-12-12

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

Comments

Post a Comment

Popular posts from this blog

Ayurvedic Products Market Outlook, Trend, Growth and Share Estimation Analysis and Forecast 2020-2030

Image
  Global Ayurvedic Products Market Overview Ayurvedic Products are generally used in personal care and healthcare products. Ayurvedic products originated from India, and thus, the concentration of ayurvedic product suppliers is the highest in the country. According to the latest research reports Due to growing inclination for natural treatment, the Ayurvedic Products Market , size is projected to reach USD 28830.5 Million by 2030 at 12.3% CAGR. Many factors are influencing a significant rise in the growth rate between during forecast periods. Increasing adoption of traditional methods for medicinal purposes is observed to cause a significant boost in the global Ayurvedic Products Market With a rise in the working woman population, rising disposable income, and a growing inclination towards chemical free and herbal cosmetics are some of the primary factors contributing to the ascension of the global ayurvedic market. Apart from personal care, ayurvedic healthcare products are...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more

Breast Cancer Market 2022-2027 Worldwide Demand and Growth Analysis Report 2022-2027

Image
  Breast Cancer is the second-most common type of cancer in women and one of the paramount concerns, globally. According to WHO, every year, around 200,000 new cases get registered, and the digits are continuously increasing. Many statistics show that breast cancer is more prevalent in developed countries such as the UK, the US, and Australia as their women are more prone to acquire the disease. This doesn’t mean that women from developing countries like India and China are out of breast cancer’s radar. On the contrary, they are more vulnerable than women from developed regions. Unavailability of proper treatment due to the lack of funds and awareness towards the government’s programs is killing them more than breast cancer can. Advancements in medical science and biotechnology have improved the outlook of diagnosis. However, the recovery is still challenging as survivors adjust to the scars that remain mentally and physically. Surprisingly, the Breast Cancer Market is still a...
Read more